Effect of somatostatin on plasma C-peptide immunoreactivity in normal man.
The effect of somatostatin on plasma C-peptide immunoreactivity was studied in seven normal men following an intravenous 25 g glucose load. No elevation in plasma insulin was observed and similarly no rise in plasma C-peptide immunoreactivity occurred, indicating that somatostatin inhibits glucose-induced C-peptide release as well as insulin release.
D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002096:C-Peptide / Q000097:blood* / Q000276:immunology; D005947:Glucose; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D011863:Radioimmunoassay; D013004:Somatostatin
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D010455:Peptides; D013004:Somatostatin; D005947:Glucose